New daily pill aims to shed pounds in obesity trial

NCT ID NCT07497880

First seen Apr 13, 2026

Summary

This study tests an experimental oral medication, KAI-7535, taken once daily to help people with obesity or overweight lose weight. About 320 adults with at least one weight-related condition (like high blood pressure or sleep apnea) will receive either the drug or a placebo for 44 weeks. The main goal is to see how much body weight changes from the start of the study.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kailera Clinical Site

    RECRUITING

    Chandler, Arizona, 85225, United States

  • Kailera Clinical Site

    RECRUITING

    Irvine, California, 92614, United States

  • Kailera Clinical Site

    RECRUITING

    Lincoln, California, 95648, United States

  • Kailera Clinical Site

    RECRUITING

    Northridge, California, 91325, United States

  • Kailera Clinical Site

    RECRUITING

    Hamden, Connecticut, 06517, United States

  • Kailera Clinical Site

    RECRUITING

    Jacksonville, Florida, 32256, United States

  • Kailera Clinical Site

    RECRUITING

    Jupiter, Florida, 33458, United States

  • Kailera Clinical Site

    RECRUITING

    Pembroke Pines, Florida, 33024, United States

  • Kailera Clinical Site

    RECRUITING

    Decatur, Georgia, 30030, United States

  • Kailera Clinical Site

    RECRUITING

    Skokie, Illinois, 60077, United States

  • Kailera Clinical Site

    RECRUITING

    South Bend, Indiana, 46617, United States

  • Kailera Clinical Site

    RECRUITING

    Kenner, Louisiana, 70065, United States

  • Kailera Clinical Site

    RECRUITING

    Garden City, Michigan, 48135, United States

  • Kailera Clinical Site

    RECRUITING

    Jefferson City, Missouri, 65109, United States

  • Kailera Clinical Site

    RECRUITING

    Kansas City, Missouri, 64151, United States

  • Kailera Clinical Site

    RECRUITING

    Spartanburg, South Carolina, 29303, United States

  • Kailera Clinical Site

    RECRUITING

    Knoxville, Tennessee, 37909, United States

  • Kailera Clinical Site

    RECRUITING

    Austin, Texas, 78757, United States

  • Kailera Clinical Site

    RECRUITING

    Brownsville, Texas, 78520, United States

  • Kailera Clinical Site

    RECRUITING

    Farmers Branch, Texas, 75234, United States

  • Kailera Clinical Site

    RECRUITING

    San Antonio, Texas, 78222, United States

  • Kailera Clinical Site

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Kailera Clinical Site

    RECRUITING

    Sugar Land, Texas, 77479, United States

Conditions

The condition(s) this trial relates to.

diabetes mellitus Obesity obesity disorder Overweight type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.